A detailed history of Legal & General Group PLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 2,947 shares of SERA stock, worth $12,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,947
Previous 3,069 3.98%
Holding current value
$12,023
Previous $23,000 8.7%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$6.03 - $8.83 $735 - $1,077
-122 Reduced 3.98%
2,947 $25,000
Q3 2024

Feb 28, 2025

BUY
$5.29 - $8.43 $645 - $1,028
122 Added 4.14%
3,069 $23,000
Q2 2024

Aug 14, 2024

BUY
$5.6 - $11.69 $17,186 - $35,876
3,069 New
3,069 $18,000
Q2 2022

Aug 22, 2022

SELL
$1.2 - $3.62 $609 - $1,838
-508 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.96 - $8.8 $408 - $1,214
138 Added 37.3%
508 $2,000
Q3 2021

Nov 15, 2021

BUY
$7.9 - $13.04 $2,923 - $4,824
370 New
370 $4,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $121M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.